| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hexosyltransferase activity | 6.95e-05 | 211 | 66 | 6 | GO:0016758 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.52e-04 | 153 | 66 | 5 | GO:0008194 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 2.09e-04 | 35 | 66 | 3 | GO:0015020 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1B CACNA1E KCNC3 SCN4A SLC6A20 COX4I2 SLC15A3 SLC23A2 KCNK4 | 2.10e-04 | 627 | 66 | 9 | GO:0022890 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1B CACNA1E KCNC3 SCN4A SLC6A20 COX4I2 SLC15A3 SLC23A2 KCNK4 | 3.21e-04 | 664 | 66 | 9 | GO:0008324 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 3.76e-04 | 288 | 66 | 6 | GO:0016757 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 3.82e-04 | 9 | 66 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 3.82e-04 | 9 | 66 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1B CACNA1E ABCA4 KCNC3 SCN4A SLC6A20 SLC6A19 SLC35B2 COX4I2 SLC15A3 SLC23A2 KCNK4 | 4.34e-04 | 1180 | 66 | 12 | GO:0022857 |
| GeneOntologyMolecularFunction | acetylglucosaminyltransferase activity | 5.04e-04 | 47 | 66 | 3 | GO:0008375 | |
| GeneOntologyMolecularFunction | retinoid binding | 5.36e-04 | 48 | 66 | 3 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 5.70e-04 | 49 | 66 | 3 | GO:0019840 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1B CACNA1E KCNC3 SCN4A SLC6A20 COX4I2 SLC15A3 SLC23A2 KCNK4 | 8.32e-04 | 758 | 66 | 9 | GO:0015318 |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 8.45e-04 | 465 | 66 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1B CACNA1E ABCA4 KCNC3 SCN4A SLC6A20 SLC6A19 SLC35B2 COX4I2 SLC15A3 SLC23A2 KCNK4 | 9.50e-04 | 1289 | 66 | 12 | GO:0005215 |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 9.54e-04 | 14 | 66 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | 9.81e-04 | 477 | 66 | 7 | GO:0022804 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1B CACNA1E KCNC3 SCN4A SLC6A20 COX4I2 SLC15A3 SLC23A2 KCNK4 | 1.14e-03 | 793 | 66 | 9 | GO:0015075 |
| GeneOntologyMolecularFunction | symporter activity | 1.54e-03 | 150 | 66 | 4 | GO:0015293 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 1.61e-03 | 152 | 66 | 4 | GO:0022843 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.96e-03 | 296 | 66 | 5 | GO:0015291 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.10e-03 | 182 | 66 | 4 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.22e-03 | 184 | 66 | 4 | GO:0022832 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 3.85e-03 | 28 | 66 | 2 | GO:0001972 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.51e-03 | 343 | 66 | 5 | GO:0005261 | |
| GeneOntologyMolecularFunction | deaminase activity | 5.64e-03 | 34 | 66 | 2 | GO:0019239 | |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.97e-03 | 35 | 66 | 2 | GO:0005343 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme binding | 6.30e-03 | 36 | 66 | 2 | GO:0031624 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines | 6.30e-03 | 36 | 66 | 2 | GO:0016814 | |
| GeneOntologyMolecularFunction | vitamin transmembrane transporter activity | 6.30e-03 | 36 | 66 | 2 | GO:0090482 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.19e-03 | 119 | 66 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 8.12e-03 | 41 | 66 | 2 | GO:0015175 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme binding | 8.51e-03 | 42 | 66 | 2 | GO:0044390 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B SLC35G1 CACNA1E KCNC3 SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 KCNK4 | 2.68e-05 | 922 | 65 | 12 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B SLC35G1 CACNA1E KCNC3 SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 KCNK4 | 3.30e-05 | 942 | 65 | 12 | GO:0098655 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 5.34e-05 | 310 | 65 | 7 | GO:0005996 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B SLC35G1 CACNA1E KCNC3 DSPP SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 KCNK4 | 5.46e-05 | 1157 | 65 | 13 | GO:0006812 |
| GeneOntologyBiologicalProcess | glycoprotein metabolic process | 5.97e-05 | 430 | 65 | 8 | GO:0009100 | |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B SLC35G1 CACNA1E KCNC3 SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 KCNK4 | 6.93e-05 | 1017 | 65 | 12 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B SLC35G1 CACNA1E KCNC3 DSPP SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 LEP KCNK4 | 7.78e-05 | 1374 | 65 | 14 | GO:0006811 |
| GeneOntologyBiologicalProcess | carbohydrate derivative metabolic process | AMPD3 B3GLCT GALT PEMT B4GAT1 ELOVL5 DHDDS SLC35B2 ADAMTS13 FUT8 LEP APOBEC3A B3GNT8 | 9.84e-05 | 1226 | 65 | 13 | GO:1901135 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B SLC35G1 CACNA1E KCNC3 SCN4A SLC6A20 SLC6A19 RGS9 COX4I2 SLC15A3 SLC23A2 KCNK4 | 1.65e-04 | 1115 | 65 | 12 | GO:0034220 |
| GeneOntologyBiologicalProcess | positive regulation of follicle-stimulating hormone secretion | 2.03e-04 | 7 | 65 | 2 | GO:0046881 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B SLC35G1 CACNA1E KCNC3 DSPP SCN4A SLC6A20 SLC6A19 RGS9 SLC23A2 KCNK4 | 2.66e-04 | 1000 | 65 | 11 | GO:0030001 |
| GeneOntologyBiologicalProcess | hexose metabolic process | 2.70e-04 | 284 | 65 | 6 | GO:0019318 | |
| GeneOntologyBiologicalProcess | biphenyl catabolic process | 2.70e-04 | 8 | 65 | 2 | GO:0070980 | |
| GeneOntologyBiologicalProcess | positive regulation of gonadotropin secretion | 2.70e-04 | 8 | 65 | 2 | GO:0032278 | |
| GeneOntologyBiologicalProcess | poly-N-acetyllactosamine biosynthetic process | 3.47e-04 | 9 | 65 | 2 | GO:0030311 | |
| GeneOntologyBiologicalProcess | regulation of follicle-stimulating hormone secretion | 3.47e-04 | 9 | 65 | 2 | GO:0046880 | |
| GeneOntologyBiologicalProcess | poly-N-acetyllactosamine metabolic process | 4.33e-04 | 10 | 65 | 2 | GO:0030309 | |
| GeneOntologyBiologicalProcess | biphenyl metabolic process | 4.33e-04 | 10 | 65 | 2 | GO:0018879 | |
| GeneOntologyBiologicalProcess | circulatory system process | 4.64e-04 | 733 | 65 | 9 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 5.27e-04 | 118 | 65 | 4 | GO:0046928 | |
| GeneOntologyBiologicalProcess | follicle-stimulating hormone secretion | 5.28e-04 | 11 | 65 | 2 | GO:0046884 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | SLC35G1 B3GLCT PEMT AUP1 EBPL MARCHF6 PTDSS1 ELOVL5 UGT2B4 UGT2B7 DHDDS BFAR SLC35B2 ERMARD CHRM3 PHTF1 | 1.51e-06 | 1293 | 65 | 16 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | SLC35G1 B3GLCT PEMT AUP1 EBPL MARCHF6 PTDSS1 ELOVL5 UGT2B4 UGT2B7 DHDDS BFAR SLC35B2 ERMARD CHRM3 PHTF1 | 1.61e-06 | 1299 | 65 | 16 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | SLC35G1 B3GLCT PEMT AUP1 EBPL MARCHF6 PTDSS1 ELOVL5 UGT2B4 UGT2B7 DHDDS BFAR SLC35B2 ERMARD CHRM3 PHTF1 | 2.13e-06 | 1327 | 65 | 16 | GO:0042175 |
| GeneOntologyCellularComponent | presynaptic membrane | 2.20e-04 | 277 | 65 | 6 | GO:0042734 | |
| GeneOntologyCellularComponent | synaptic membrane | 4.35e-04 | 583 | 65 | 8 | GO:0097060 | |
| GeneOntologyCellularComponent | cation channel complex | 8.21e-04 | 235 | 65 | 5 | GO:0034703 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 1.61e-03 | 405 | 65 | 6 | GO:0045211 | |
| MousePheno | abnormal glucose tolerance | CACNA1B CACNA1E RNF123 DSPP PIK3CA SCN4A MARCHF6 ELOVL5 COX4I2 CHRM3 LEP UNC13A | 7.84e-06 | 787 | 47 | 12 | MP:0005291 |
| MousePheno | abnormal frequency of paradoxical sleep | 3.32e-05 | 19 | 47 | 3 | MP:0003194 | |
| MousePheno | decreased circulating glucagon level | 3.90e-05 | 20 | 47 | 3 | MP:0002696 | |
| MousePheno | decreased circulating leptin level | 4.55e-05 | 118 | 47 | 5 | MP:0005668 | |
| MousePheno | abnormal paradoxical sleep pattern | 6.02e-05 | 23 | 47 | 3 | MP:0012288 | |
| MousePheno | decreased circulating hormone level | 7.68e-05 | 551 | 47 | 9 | MP:0014457 | |
| MousePheno | improved glucose tolerance | 8.00e-05 | 315 | 47 | 7 | MP:0005292 | |
| MousePheno | abnormal hepatobiliary system physiology | 8.64e-05 | 433 | 47 | 8 | MP:0002139 | |
| MousePheno | abnormal circulating leptin level | 1.31e-04 | 236 | 47 | 6 | MP:0005667 | |
| MousePheno | abnormal respiratory system physiology | AMPD3 NADSYN1 NTRK3 SCN4A MARCHF6 COX4I2 FUT8 SLC23A2 CHRM3 LEP UNC13A | 1.47e-04 | 897 | 47 | 11 | MP:0002133 |
| MousePheno | decreased hormone level | 2.25e-04 | 635 | 47 | 9 | MP:0014455 | |
| MousePheno | abnormal circulating glucagon level | 3.23e-04 | 40 | 47 | 3 | MP:0002695 | |
| MousePheno | abnormal liver physiology | 3.54e-04 | 401 | 47 | 7 | MP:0000609 | |
| MousePheno | decreased glucagon secretion | 3.92e-04 | 9 | 47 | 2 | MP:0002711 | |
| MousePheno | fragmentation of sleep/wake states | 3.92e-04 | 9 | 47 | 2 | MP:0009436 | |
| MousePheno | decreased insulin secretion | 5.16e-04 | 111 | 47 | 4 | MP:0003059 | |
| Domain | Channel_four-helix_dom | 3.81e-05 | 57 | 62 | 4 | IPR027359 | |
| Domain | - | 3.81e-05 | 57 | 62 | 4 | 1.20.120.350 | |
| Domain | Na/ntran_symport_orphan | 1.08e-04 | 5 | 62 | 2 | IPR002438 | |
| Domain | VDCC_a1su_IQ | 2.25e-04 | 7 | 62 | 2 | IPR014873 | |
| Domain | GPHH | 2.25e-04 | 7 | 62 | 2 | PF16905 | |
| Domain | GPHH_dom | 2.25e-04 | 7 | 62 | 2 | IPR031649 | |
| Domain | Ca_chan_IQ | 2.25e-04 | 7 | 62 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.25e-04 | 7 | 62 | 2 | PF08763 | |
| Domain | VDCCAlpha1 | 4.80e-04 | 10 | 62 | 2 | IPR002077 | |
| Domain | Ion_trans_dom | 5.59e-04 | 114 | 62 | 4 | IPR005821 | |
| Domain | Ion_trans | 5.59e-04 | 114 | 62 | 4 | PF00520 | |
| Domain | SNF | 1.79e-03 | 19 | 62 | 2 | PF00209 | |
| Domain | NA_NEUROTRAN_SYMP_1 | 1.79e-03 | 19 | 62 | 2 | PS00610 | |
| Domain | NA_NEUROTRAN_SYMP_3 | 1.79e-03 | 19 | 62 | 2 | PS50267 | |
| Domain | Na/ntran_symport | 1.79e-03 | 19 | 62 | 2 | IPR000175 | |
| Domain | UDPGT | 2.19e-03 | 21 | 62 | 2 | PF00201 | |
| Domain | UDPGT | 2.19e-03 | 21 | 62 | 2 | PS00375 | |
| Domain | UDP_glucos_trans | 2.19e-03 | 21 | 62 | 2 | IPR002213 | |
| Pubmed | Insulin resistance and diabetes caused by genetic or diet-induced KBTBD2 deficiency in mice. | 5.44e-07 | 9 | 66 | 3 | 27708159 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10222050 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15610184 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 27999401 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 18239469 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 17263731 | ||
| Pubmed | Effects of ablation of N- and R-type Ca(2+) channels on pain transmission. | 3.55e-06 | 2 | 66 | 2 | 12074836 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15319348 | ||
| Pubmed | Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency. | 3.55e-06 | 2 | 66 | 2 | 17084710 | |
| Pubmed | Acute physical exercise increases PI3K-p110α protein content in the hypothalamus of obese mice. | 3.55e-06 | 2 | 66 | 2 | 33094520 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 2826474 | ||
| Pubmed | Molecular cloning of complementary DNA encoding one of the human pancreatic protease E isozymes. | 3.55e-06 | 2 | 66 | 2 | 2460440 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21991326 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.97e-06 | 139 | 66 | 5 | 16985003 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 7835904 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 29138287 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 16174864 | ||
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 38996073 | ||
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.06e-05 | 3 | 66 | 2 | 24523520 | |
| Pubmed | 1.06e-05 | 3 | 66 | 2 | 22092298 | ||
| Pubmed | A large-scale candidate gene association study of age at menarche and age at natural menopause. | 1.41e-05 | 275 | 66 | 6 | 20734064 | |
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 2.12e-05 | 4 | 66 | 2 | 32616470 | |
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 21123564 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 23417417 | ||
| Pubmed | 2.12e-05 | 4 | 66 | 2 | 16849011 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 2.12e-05 | 4 | 66 | 2 | 37141091 | |
| Pubmed | Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carcinoma. | 2.12e-05 | 4 | 66 | 2 | 20008098 | |
| Pubmed | Essential role for collectrin in renal amino acid transport. | 2.12e-05 | 4 | 66 | 2 | 17167413 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 8825650 | ||
| Pubmed | Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors. | 3.53e-05 | 5 | 66 | 2 | 25534429 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 15318931 | ||
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 15451373 | ||
| Pubmed | Disentangling the Roles of RIM and Munc13 in Synaptic Vesicle Localization and Neurotransmission. | 3.53e-05 | 5 | 66 | 2 | 33139401 | |
| Pubmed | Complex Formation of Human Proelastases with Procarboxypeptidases A1 and A2. | 3.53e-05 | 5 | 66 | 2 | 27358403 | |
| Pubmed | 3.53e-05 | 5 | 66 | 2 | 11296258 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 5.29e-05 | 6 | 66 | 2 | 35324301 | |
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 5.29e-05 | 6 | 66 | 2 | 12827191 | |
| Pubmed | 5.29e-05 | 6 | 66 | 2 | 9238069 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 7.40e-05 | 7 | 66 | 2 | 35176221 | |
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 20492333 | ||
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 26074487 | ||
| Pubmed | 7.40e-05 | 7 | 66 | 2 | 23312282 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 32093886 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 18052087 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 28330839 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 10748067 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 18719240 | ||
| Pubmed | 9.86e-05 | 8 | 66 | 2 | 20142249 | ||
| Pubmed | 1.27e-04 | 9 | 66 | 2 | 16382099 | ||
| Pubmed | 1.58e-04 | 10 | 66 | 2 | 19585519 | ||
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 2.31e-04 | 12 | 66 | 2 | 20308471 | |
| Pubmed | 2.31e-04 | 12 | 66 | 2 | 18161889 | ||
| Pubmed | 2.52e-04 | 296 | 66 | 5 | 34186245 | ||
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | 3.52e-04 | 697 | 66 | 7 | 28298427 | |
| Pubmed | Dynamic expression of chymotrypsin-like elastase 1 over the course of murine lung development. | 3.67e-04 | 15 | 66 | 2 | 24793170 | |
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 20188150 | ||
| Pubmed | 3.67e-04 | 15 | 66 | 2 | 24453333 | ||
| Pubmed | Identification of cAMP analogue inducible genes in RAW264 macrophages. | 4.18e-04 | 16 | 66 | 2 | 11004510 | |
| Pubmed | Association analysis of 3p21 with Crohn's disease in a New Zealand population. | 4.74e-04 | 17 | 66 | 2 | 20307617 | |
| Pubmed | 5.06e-04 | 193 | 66 | 4 | 19343046 | ||
| Pubmed | 5.32e-04 | 18 | 66 | 2 | 20056724 | ||
| Pubmed | The repertoire of solute carriers of family 6: identification of new human and rodent genes. | 7.28e-04 | 21 | 66 | 2 | 16125675 | |
| Pubmed | 7.28e-04 | 21 | 66 | 2 | 15452121 | ||
| Pubmed | 7.28e-04 | 21 | 66 | 2 | 16518820 | ||
| Pubmed | 8.81e-04 | 814 | 66 | 7 | 23251661 | ||
| Pubmed | 1.59e-03 | 31 | 66 | 2 | 22178591 | ||
| Pubmed | 1.59e-03 | 31 | 66 | 2 | 27321927 | ||
| Pubmed | Amino acid transport across mammalian intestinal and renal epithelia. | 1.59e-03 | 31 | 66 | 2 | 18195088 | |
| Pubmed | 1.70e-03 | 32 | 66 | 2 | 19320717 | ||
| Cytoband | 4q13 | 2.11e-04 | 15 | 66 | 2 | 4q13 | |
| GeneFamily | Solute carriers | 3.66e-04 | 395 | 44 | 6 | 752 | |
| GeneFamily | Beta 3-glycosyltransferases | 1.54e-03 | 24 | 44 | 2 | 426 | |
| GeneFamily | Calcium voltage-gated channel subunits | 1.81e-03 | 26 | 44 | 2 | 253 | |
| GeneFamily | UDP glucuronosyltransferases | 2.74e-03 | 32 | 44 | 2 | 363 | |
| Drug | brilliant blue | 1.07e-06 | 27 | 66 | 4 | CID000017559 | |
| Drug | sipatrigine | 3.96e-06 | 37 | 66 | 4 | CID000060803 | |
| Drug | mefenamic acid | 3.96e-06 | 37 | 66 | 4 | CID000004044 | |
| Drug | norcepharadione B | 8.28e-06 | 2 | 66 | 2 | CID000189168 | |
| Drug | aristolactam AII | 8.28e-06 | 2 | 66 | 2 | CID000148657 | |
| Drug | alkosin | 8.28e-06 | 2 | 66 | 2 | CID005488638 | |
| Drug | piperolactam A | 8.28e-06 | 2 | 66 | 2 | CID003081016 | |
| Drug | valproate | 1.41e-05 | 381 | 66 | 8 | CID000003121 | |
| Drug | chloramine-T | 1.42e-05 | 106 | 66 | 5 | CID000031388 | |
| Drug | chromic phosphate | 2.48e-05 | 3 | 66 | 2 | CID000062673 | |
| Drug | 5 alpha-dihydroaldosterone | 2.48e-05 | 3 | 66 | 2 | CID003036614 | |
| Drug | halazepam | 2.56e-05 | 20 | 66 | 3 | CID000031640 | |
| Drug | AS-3201 | 4.51e-05 | 24 | 66 | 3 | CID000153948 | |
| Drug | AC 110 | 4.95e-05 | 4 | 66 | 2 | CID000022860 | |
| Drug | 2-PP | 4.95e-05 | 4 | 66 | 2 | CID005274974 | |
| Drug | AC1Q4I5I | 4.95e-05 | 4 | 66 | 2 | CID000194288 | |
| Drug | mAHP | 6.47e-05 | 27 | 66 | 3 | CID000220531 | |
| Drug | NSC-37538 | 8.23e-05 | 5 | 66 | 2 | CID000014464 | |
| Drug | hyodeoxycholic acid | 8.23e-05 | 5 | 66 | 2 | ctd:C010471 | |
| Drug | Amobarbital | 8.23e-05 | 5 | 66 | 2 | ctd:D000654 | |
| Drug | almagel | 8.23e-05 | 5 | 66 | 2 | CID003080942 | |
| Drug | phenolphthalin | 8.23e-05 | 5 | 66 | 2 | CID000066494 | |
| Drug | beta-guanidinopropionic acid | 8.93e-05 | 30 | 66 | 3 | CID000067701 | |
| Drug | Tr-J | 1.09e-04 | 32 | 66 | 3 | CID000015133 | |
| Drug | N-acetyllactosamine | 1.14e-04 | 164 | 66 | 5 | CID000000245 | |
| Drug | 2-hydroxyestriol | 1.23e-04 | 6 | 66 | 2 | CID000014688 | |
| Drug | 3,4-dihydroquinazoline | 1.23e-04 | 6 | 66 | 2 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.23e-04 | 6 | 66 | 2 | CID000133976 | |
| Drug | fenfluramine | 1.68e-04 | 178 | 66 | 5 | CID000003337 | |
| Drug | GBHA | 1.72e-04 | 7 | 66 | 2 | CID005356911 | |
| Drug | oxazepam glucuronide | 1.72e-04 | 7 | 66 | 2 | CID000160870 | |
| Drug | APMPA | 1.72e-04 | 7 | 66 | 2 | CID000512300 | |
| Drug | ranirestat | 1.72e-04 | 7 | 66 | 2 | ctd:C115070 | |
| Disease | vitamin D measurement, COVID-19 | 4.22e-06 | 49 | 65 | 4 | EFO_0004631, MONDO_0100096 | |
| Disease | HYPERGLYCINURIA (disorder) | 1.43e-05 | 3 | 65 | 2 | C0543541 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.43e-05 | 3 | 65 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | migraine (implicated_via_orthology) | 2.86e-05 | 4 | 65 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Iminoglycinuria | 2.86e-05 | 4 | 65 | 2 | C0268654 | |
| Disease | vitamin D deficiency | 7.51e-05 | 37 | 65 | 3 | EFO_0003762 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 9.96e-05 | 7 | 65 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Seizures | 1.21e-04 | 218 | 65 | 5 | C0036572 | |
| Disease | plasma clozapine-to-N-desmethylclozapine ratio measurement | 1.70e-04 | 9 | 65 | 2 | EFO_0600040 | |
| Disease | X-19141 measurement | 3.67e-04 | 13 | 65 | 2 | EFO_0800799 | |
| Disease | epilepsy (implicated_via_orthology) | 4.67e-04 | 163 | 65 | 4 | DOID:1826 (implicated_via_orthology) | |
| Disease | Schizophrenia | 6.96e-04 | 883 | 65 | 8 | C0036341 | |
| Disease | X-24947 measurement | 1.07e-03 | 22 | 65 | 2 | EFO_0800910 | |
| Disease | osteoporosis (biomarker_via_orthology) | 1.07e-03 | 22 | 65 | 2 | DOID:11476 (biomarker_via_orthology) | |
| Disease | Carcinoma of lung | 1.17e-03 | 23 | 65 | 2 | C0684249 | |
| Disease | Disorder of eye | 1.24e-03 | 212 | 65 | 4 | C0015397 | |
| Disease | Hyperplasia | 1.74e-03 | 28 | 65 | 2 | C0020507 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YPAWFEPFVIQWLDE | 1141 | Q9UPW8 | |
| WNIDPVKVYFTWLAP | 466 | Q6Y288 | |
| WNWLYFIPLIIIGSF | 326 | Q15878 | |
| GTPLPWYFLLQESYW | 866 | P78363 | |
| AYVVPWQDPWEPFYV | 316 | O43505 | |
| PAQIYRVTWFISWSP | 86 | P31941 | |
| QYFPETWLWDLFPIG | 731 | A8K2U0 | |
| SFVLWAPAILFWQYF | 196 | P20309 | |
| YFCIWAVAWAIPVPQ | 6 | Q9NZW4 | |
| PFLEQLYCWAPWVQT | 106 | Q96M86 | |
| WNWLYFIPLIIIGSF | 331 | Q00975 | |
| TDTEAFWQPQPWFVV | 676 | A6H8M9 | |
| FWQPQPWFVVVLTAT | 681 | A6H8M9 | |
| TYFQPKPRQAWVWAA | 676 | Q76LX8 | |
| SPEEWPNLAYWFIQH | 446 | Q01432 | |
| YRFQTPYFWPTQQWP | 101 | O75916 | |
| WEIFTYGKQPWFQLS | 761 | Q16288 | |
| VIWPCTFPLGWLYFQ | 221 | Q9NYP7 | |
| QDSPAYQPLVWFWIL | 226 | Q9NYG8 | |
| KTVWLYLQAWPNPVF | 16 | Q6DN72 | |
| YWFDAQQNTWFPKTP | 351 | Q8IY47 | |
| WLWPYLFYVQAVPIQ | 11 | P41159 | |
| LDQTPLFYPWQDWAL | 751 | O60337 | |
| WLYLFFFNGVWVLIP | 166 | Q9BY08 | |
| LFWRSRVTNPINPWY | 471 | Q8N159 | |
| FIQPWGPKAYITWIT | 191 | P30559 | |
| FPWPEQVWFKASRVY | 201 | P48146 | |
| PRWNEWLNYDIYIPD | 381 | P42336 | |
| TITFNPLYWNVVARW | 21 | Q9UBM1 | |
| WPLIPQFVCNCLFYW | 411 | Q9NZS9 | |
| VPYSWPWQVSLQYEK | 36 | P09093 | |
| VLVPFWATWPYQTLL | 241 | P07902 | |
| VPYSWPWQVSLQYEK | 36 | P08861 | |
| WWFGTVLSQEPYQPQ | 1081 | Q9NSI6 | |
| FQELGWERWIVYPPS | 271 | P05111 | |
| EIRYAPWFQWTSFPE | 91 | Q5T6L9 | |
| IPLPFAYWNQQQWRL | 66 | Q7Z7M8 | |
| VFQPVLWPEYTFWNL | 226 | Q86SQ9 | |
| YNAAPLSIWWQIPQY | 451 | Q8IY34 | |
| AALVIWWQRVYVFPP | 116 | Q96KJ9 | |
| WWVSQFVKYLIRPQP | 326 | Q9BYC5 | |
| IMWYLFNSFQEPLPW | 136 | Q695T7 | |
| YDQPWEWNRVTIPAL | 336 | Q15464 | |
| VRWPPPFNDTNTTWY | 281 | P35499 | |
| WGVPQLLWYLVFLQP | 26 | Q17RQ9 | |
| LLPLNPNLTVFYWWI | 896 | Q96PQ0 | |
| WYLFHSFQDPLPWSV | 111 | Q9NP91 | |
| LWSLFVPFTVYQVRW | 211 | Q9Y679 | |
| LEVLPWPTEWIFNPY | 71 | Q5JXX7 | |
| EWPWQYRFPPFFTLQ | 6 | Q9BRG1 | |
| VVFFPLFSNWWIQVT | 81 | Q9UMS5 | |
| WRVWTPLQFININYV | 156 | Q9NR77 | |
| LLVAPWFKVPYPFQW | 356 | Q9UGH3 | |
| WLIRNYWDFQFPHPL | 256 | P06133 | |
| APPESWTQLWFFRFV | 26 | Q8TB61 | |
| APYEQRPWAQTNWIL | 956 | Q5XPI4 | |
| YLFPPNFWIWTLATH | 51 | Q12893 | |
| PFLTQYHTVWIPWNV | 921 | Q9P273 | |
| FLVTDWNPLTVWFYR | 341 | Q9Y4R7 | |
| FRYLQEIIVWPPLWD | 491 | Q6ZR37 | |
| FIFQIIFFNNVPTWW | 326 | Q2M3R5 | |
| WLIRNSWNFQFPYPL | 256 | P16662 | |
| LFPDPVVQWLYQYWP | 36 | Q53S58 | |
| FLKVPIWWYQLQGPS | 931 | Q9NVE5 | |
| QFTPASWTYVRWFDP | 266 | P48651 | |
| YFKNIPIGFWWAVVT | 486 | Q14003 | |
| LRPFLYNTSWPWQFR | 671 | Q6IA69 |